Skip to main content
SpringerLink
Log in

Withdrawal syndrome after co-medication of opioid maintenance therapy with nalmefene: unrecognized interaction

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Donnerstag N, Schneider T, Lüthi A, Taegtmeyer A, Raetz Bravo A, Mehlig A (2015) Severe opioid withdrawal syndrome after a single dose of nalmefene. Eur J Clin Pharmacol 71:1025–1026

    Article  PubMed  Google Scholar 

  2. Jouanjus E, Gibaja V, Kahn JP, Haramburu F, Daveluy A (2015) Signal identification in addictovigilance: the functioning of the French system. Therapie 70:123–131

    Article  Google Scholar 

  3. Résumé des caractéristiques du produit – Selincro® : Ministère de la santé : Base de données publique des médicaments. Disponible à : http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=63957761

  4. « PRAC assessment report » du nalméfène (pages 37–38): http://www.ema.europa.eu/docs/en_GB/document_library/Minutes/2015/04/WC500185968.pdf.

  5. Lemesle F, Lemesle F, Nicola W, Pierre J-BA (2010) First case of stress cardiomyopathy as a result of methadone withdrawal secondary to drug-drug interaction. Am J Emerg Med 28:387

    Article  PubMed  Google Scholar 

  6. Kugasia IR, Shabarek N (2014) Opiate withdrawal complicated by tetany and cardiac arrest. Case Rep Crit Care 2014:295401. doi:10.1155/2014/295401

    PubMed Central  PubMed  Google Scholar 

  7. Dupouy J, Poutrain JC, Lapeyre-Mestre M (2011) Naltrexone and opiate substitutive treatment. Therapie 66:549–552

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

  1. Centre d’Addictovigilance, Hôpital Lapeyronie, Centre Hospitalier Régional Universitaire et Université de Montpellier, Montpellier, France

    Caroline Diot, Céline Eiden & Hélène Peyrière

  2. Centre d’Addictovigilance, Service de Pharmacologie Clinique, Hôpitaux de Toulouse, Toulouse, France - Pharmacoépidémiologie, UMR1027 INSERM, Université de Toulouse III, Toulouse, France

    Anne Roussin

  3. Centre d’Addictovigilance, Hôpital Fernand Widal Paris, Paris, France

    Anne Batisse

  4. Centre d’Addictovigilance, CHU Lyon, Lyon, France

    Alexandra Boucher

  5. Service de Pharmacologie clinique et Vigilances, Centre d’Addictovigilance, CHU Poitiers, Poitiers, France

    François Chavant

  6. Centre d’addictovigilance, Service de pharmacologie médicale, CHU de Bordeaux, INSERM, U657, F-33000, Bordeaux, France

    Amélie Daveluy

  7. Département de Médecine Interne et Addictologie, Hôpital Saint-Eloi, CHU Montpellier, Montpellier, France

    Hélène Donadieu-Rigole

Authors
  1. Caroline Diot
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Céline Eiden
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anne Roussin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anne Batisse
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alexandra Boucher
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. François Chavant
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Amélie Daveluy
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hélène Donadieu-Rigole
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hélène Peyrière
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

et le réseau des centres français d’addictovigilance

Corresponding author

Correspondence to Hélène Peyrière.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Diot, C., Eiden, C., Roussin, A. et al. Withdrawal syndrome after co-medication of opioid maintenance therapy with nalmefene: unrecognized interaction. Eur J Clin Pharmacol 71, 1539–1540 (2015). https://doi.org/10.1007/s00228-015-1931-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-015-1931-y

Keywords

Search

Navigation